Like most pharma stocks, FDA approval should prompt a pump and dump and as it has been said, the real gains will only be driven by further clinical testing and results with the future big gains to be sales-driven.
In this for the long term though.
DYOR
- Forums
- ASX - By Stock
- hazard a guess?
Like most pharma stocks, FDA approval should prompt a pump and...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)